RYH:ARCA-Guggenheim S&P 500 Equal Weight Healthcare

ETF | Others | NYSE Arca

Last Closing

USD 197.4

Change

-0.20 (-0.10)%

Market Cap

USD 0.47B

Volume

9.60K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500? Equal Weight Index Health Care Total Return. The underlying index is an unmanaged equal weighted version of the S&P 500? Health Care Index that consists of the common stocks of the following industries: health care equipment and supplies, health care providers and services, and biotechnology and pharmaceuticals that comprise the Health Care sector of the S&P 500? Index. The fund is non-diversified.

Inception Date: 01/11/2006

Primary Benchmark: S&P 500 Equal Weighted HC TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.4%

Management Expense Ratio: 0.40 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
3020-OL:HK X DBMSCIUSA 1.64 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-16 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
SOJE SOJE 0.00 %

-0.26 (-1.27%)

USD 65.72B
ITDC Ishares Lifepath Target Date 2.. 0.00 %

+0.02 (+0.07%)

USD 36.86B
JEPI JPMorgan Equity Premium Income.. 0.00 %

+0.09 (+0.16%)

USD 32.78B
LCR Leuthold Core ETF 0.00 %

+0.03 (+0.10%)

USD 32.52B
DTB DTB 0.00 %

+0.01 (+0.05%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2.. 0.00 %

+0.08 (+0.25%)

USD 26.11B
JPST JPMorgan Ultra-Short Income ET.. 0.00 %

-0.01 (-0.02%)

USD 22.47B
SGOV iShares® 0-3 Month Treasury B.. 0.00 %

+0.01 (+0.01%)

USD 18.58B
TSPA T. Rowe Price US Equity Resear.. 0.00 %

+0.06 (+0.18%)

USD 16.23B
DFUV Dimensional US Marketwide Valu.. 0.00 %

+0.20 (+0.49%)

USD 10.15B

ETFs Containing RYH

QRH:CA 0.00 % 1.20 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.19% 53% F 49% F
Dividend Return 0.49% 9% A- 7% C-
Total Return 11.68% 47% F 44% F
Trailing 12 Months  
Capital Gain -0.71% 36% F 43% F
Dividend Return 0.44% 6% D- 5% F
Total Return -0.28% 30% F 38% F
Trailing 5 Years  
Capital Gain 59.21% 88% B+ 80% B-
Dividend Return 3.17% 16% F 11% F
Total Return 62.37% 84% B 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 6.84% 80% B- 72% C
Dividend Return 7.31% 74% C 64% D
Total Return 0.47% 17% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 8.44% 62% D 78% C+
Risk Adjusted Return 86.60% 82% B 84% B
Market Capitalization 0.47B 77% C+ 51% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.